HB 1425 — Consultant Pharmacists

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 1425 2026 A bill to be entitled An act relating to theconsultant practicepharmacists; of pharmacy;

authorizing consultant pharmacists to provide medication management services in clinics owned by a hospital or by one or more physicians who are employed by or contracted with a hospital;

amending s.

626.8825, F.S.;

defining the term "covered prescription drug";

authorizing the administration and dispensing of covered prescription drugs as part of outpatient care;

(e) For purposes of this subsection, the term "health care facility" means an ambulatory surgical center or hospital licensed under chapter 395, an alcohol or chemical dependency Page 1 of 52 CODING:

hb1425-00hb1425-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HBCS/HB 1425 2026 (e) For purposes of this subsection, the term "health care facility" means an ambulatory surgical center or hospital licensed under chapter 395, an alcohol or chemical dependency treatment center licensed under chapter 397, an inpatient hospice licensed under part IV of chapter 400, a nursing home licensed under part II of chapter 400, an ambulatory care center as defined in s.

408.07, or a nursing home component under chapter 400 within a continuing care facility licensed under chapter 651651, , or a health care clinic licensed under part X of chapter 400 that is owned by a hospital or by one or more physicians that are employed by or contracted with a hospital.

Paragraphs (e) through (x) of subsection (1) of section 626.8825, Florida Statutes, are redesignated as paragraphs (f) through (y), respectively, and a new paragraph (e) is added to that subsection, and paragraph (e) of subsection (2) of that section is amended, to read:

626.8825 Pharmacy benefit manager transparency and accountability.— (1) DEFINITIONS.—As used in this section, the term:

(e) "Covered prescription drug" means any drug or biologic included in the pharmacy benefit manager's formulary that is paid as a pharmacy benefit at any of the pharmacy benefits plan or program network pharmacies.

(2) CONTRACTS BETWEEN A PHARMACY BENEFIT MANAGER AND A PHARMACY BENEFITS PLAN OR PROGRAM.—In addition to any other Page 2 of 5 CODING:

Words stricken are deletions;

words underlined are additions.

hb1425-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 1425 2026 requirements in the Florida Insurance Code, all contractual arrangements executed, amended, adjusted, or renewed on or after July 1, 2023, which are applicable to pharmacy benefits covered on or after January 1, 2024, between a pharmacy benefit manager and a pharmacy benefits plan or program must include, in substantial form, terms that ensure compliance with all of the following requirements and that, except to the extent not allowed by law, shall supersede any contractual terms to the contrary:

(e) Include network adequacy requirements that meet or exceed Medicare Part D program standards for convenient access to the network pharmacies set forth in 42 C.F.R.

s.

423.120(a)(1) and that:

1.

Do not limit a network to solely include affiliated pharmacies;

2.

Require a pharmacy benefit manager to offer a provider contract to licensed pharmacies physically located on the physical site of providers that are:

a.

Within the pharmacy benefits plan's or program's geographic service area and that have been specifically designated as essential providers by the Agency for Health Care Administration pursuant to s.

409.975(1)(a);

b.

Designated as cancer centers of excellence under s.

381.925, regardless of the pharmacy benefits plan's or program's geographic service area;

Page 3 of 5 CODING:

Words stricken are deletions;

words underlined are additions.

hb1425-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 1425 2026 c.

Organ transplant hospitals, regardless of the pharmacy benefits plan's or program's geographic service area;

d.

Hospitals licensed as specialty children's hospitals as defined in s.

395.002;

or e.

Regional perinatal intensive care centers as defined in s.

383.16(2), regardless of the pharmacy benefits plan's or program's geographic service area.